Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: LUMP AT THE INJECTION SITE (QUARTER SIZE OR BIGGER LUMP); DISCOMFORT AT INJECTION SITE; ARM/HAND NUMBNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient''s height, and weight were not reported. The patient''s concurrent conditions included factor v leiden mutation. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 22-MAR-2021 for prophylactic vaccination. Concomitant medications included rivaroxaban for pulmonary embolism bilateral lungs, and deep vein thrombosis right side. On an unspecified date, the subject experienced lump at the injection site (quarter size or bigger lump), discomfort at injection site, and arm/hand numbness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the lump at the injection site (quarter size or bigger lump), discomfort at injection site and arm/hand numbness was not reported. This report was non-serious.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166